EUVIMED · CrossrefZeitschrift
Portal Hypertension & Cirrhosis
ISSN 2770-5838 · Wiley
Neueste Artikel
Real‐World Distribution and Mortality Assessment of MDF and MELD Scores in Hospitalized Patients With Alcohol‐Associated Cirrhosis and Clinically Diagnosed Alcohol‐Associated Hepatitis
Primary Liver Cancer Trends Worldwide and in China: Analysis of GLOBOCAN 2022 Data and Disease Management Implications
Chinese Expert Consensus on the Use of Ultrasound‐Derived Fat Fraction in the Assessment of Metabolic Dysfunction‐Associated Steatotic Liver Disease (2025 Edition)
Effects of Shunt Position on the Prognosis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Cirrhotic Esophagogastric Variceal Bleeding
The Interplay Between Alcohol Consumption and Cardiometabolic Risk Factors in Individuals With MASLD and MetALD
Dual neovascular targets of vascular endothelial growth factor receptors and platelet‐derived growth factor receptor ameliorate thioacetamide induced liver fibrosis in rats
Issue Information
Sarcopenic obesity in liver disease: Handling both sides of the penny
Resmetirom and Thyroid Hormone Receptor‐Targeted Treatment for Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD)
Research Progress of Noninvasive Evaluation of Portal Hypertension by Blood‐Based Tests
T cells and liver fibrosis
A case of agnogenic intrahepatic arterioportal fistula complicated by gastric ulcer bleeding and progressive portal thrombosis
Issue Information
Issue Information
Issue Information
Issue Information
Endothelins and liver cirrhosis
Nonselective beta‐blockers reduce mortality in patients with acute‐on‐chronic liver failure
Impact of endoscopic ultrasound examination for deep esophageal collateral veins evaluation in liver cirrhosis patients prior to endoscopic treatment: A case series
Issue Information
Trained innate immunity and human adenovirus infection as a novel mechanism linked to the severe acute hepatitis of unknown origin in children during the COVID‐19 pandemic
The launch of Portal Hypertension & Cirrhosis in discovery and patient care
Non‐hemodynamic effects: Repurposing of nonselective beta‐blockers in cirrhosis?
Management of non‐cirrhotic extrahepatic portal vein obstruction‐related portal hypertension in adult patients
Comparison of survival prediction values of different scoring models for patients undergoing transjugular intrahepatic portal shunt: A multicenter retrospective study
Splenic artery embolization for treatment of portal hypertension due to essential thrombocythemia
Transforming one organ into another to overcome challenges in tissue engineering
The natural history of patients with compensated cirrhosis and elevated hepatic venous pressure gradient
A comprehensive review of prognostic scoring systems to predict survival after transjugular intrahepatic portosystemic shunt placement
Simultaneous splenectomy improving the outcomes of patients with hepatocellular carcinoma, cirrhosis and portal hypertension treated with hepatectomy
EUVIMED